Results 171 to 180 of about 35,850 (218)
Some of the next articles are maybe not open access.
Vaccine, 2008
The availability of two prophylactic HPV vaccines will require thorough considerations about monitoring and surveillance of those vaccinated and the general population, respectively. Vaccinated populations should be followed-up for long-term safety, sustained immune responses and vaccine efficacy.
Margaret, Stanley, Luisa Lina, Villa
openaire +2 more sources
The availability of two prophylactic HPV vaccines will require thorough considerations about monitoring and surveillance of those vaccinated and the general population, respectively. Vaccinated populations should be followed-up for long-term safety, sustained immune responses and vaccine efficacy.
Margaret, Stanley, Luisa Lina, Villa
openaire +2 more sources
Frontiers in Bioscience, 2003
Human papillomaviruses (HPV), particularly HPV type 16, are the primary etiologic agent of cervical cancer. Thus, HPV-associated cervical malignancies might be prevented or treated by induction of the appropriate virus-specific immune responses in patients.
Michelle, Moniz +3 more
openaire +2 more sources
Human papillomaviruses (HPV), particularly HPV type 16, are the primary etiologic agent of cervical cancer. Thus, HPV-associated cervical malignancies might be prevented or treated by induction of the appropriate virus-specific immune responses in patients.
Michelle, Moniz +3 more
openaire +2 more sources
Expert Opinion on Biological Therapy, 2010
Cervical cancer is a major cause of morbidity and mortality worldwide and is common in relatively young women. Cervical screening programs, while successful if properly carried out, are difficult and expensive to implement, and offer secondary, not primary prevention.
openaire +2 more sources
Cervical cancer is a major cause of morbidity and mortality worldwide and is common in relatively young women. Cervical screening programs, while successful if properly carried out, are difficult and expensive to implement, and offer secondary, not primary prevention.
openaire +2 more sources
Vaccination of Infants With HPV-77 Vaccine
Archives of Pediatrics & Adolescent Medicine, 1969IN 1966, clinical trials demonstrated that a rubella virus modified by 77 passages in African green monkey kidney cultures (GMK) was attenuated for man. 1,2 This strain (HPV-77) produced asymptomatic immunizing infections that were not communicable to contacts. The HPV-77 could be recovered from the respiratory secretions of recipients, and the vaccine
Pavilanis, Vytautas +3 more
openaire +2 more sources
BMJ, 2015
After nine years of experience, the picture remains reassuring Prophylactic vaccines against human papillomavirus (HPV) were first licensed for use in girls and young women in 2006, with more than 175 million doses distributed worldwide by 2013.1 Bivalent and quadrivalent vaccines protect against new infection with oncogenic HPV types 16 and 18 ...
openaire +2 more sources
After nine years of experience, the picture remains reassuring Prophylactic vaccines against human papillomavirus (HPV) were first licensed for use in girls and young women in 2006, with more than 175 million doses distributed worldwide by 2013.1 Bivalent and quadrivalent vaccines protect against new infection with oncogenic HPV types 16 and 18 ...
openaire +2 more sources
HPV vaccines: State of the art
Journal of Cellular Physiology, 2010AbstractCervical cancer is one of the most common types of cancer in women worldwide and is frequent in relatively young women. In the last decades, its incidence has decreased following the implementation of screening programs, mainly in developed countries.
D'Andrilli G +2 more
openaire +5 more sources
Pediatric Annals, 2019
Human papillomavirus (HPV), the most common sexually transmitted viral infection worldwide, is the causative agent for cervical cancer and attributed to anogenital cancers as well as oropharyngeal cancer. Three effective, safe, prophylactic HPV vaccines have been licensed, and studies have demonstrated decreases in HPV prevalence and HPV ...
openaire +2 more sources
Human papillomavirus (HPV), the most common sexually transmitted viral infection worldwide, is the causative agent for cervical cancer and attributed to anogenital cancers as well as oropharyngeal cancer. Three effective, safe, prophylactic HPV vaccines have been licensed, and studies have demonstrated decreases in HPV prevalence and HPV ...
openaire +2 more sources
BMJ, 2011
Most deaths from cervical cancer occur in countries without the resources to screen, treat, or vaccinate against the disease.
openaire +2 more sources
Most deaths from cervical cancer occur in countries without the resources to screen, treat, or vaccinate against the disease.
openaire +2 more sources